Heron Therapeutics
Clinical trials sponsored by Heron Therapeutics, explained in plain language.
-
New shot may slash pain and opioid use after hernia surgery
Symptom relief CompletedThis study tested a new long-acting painkiller called HTX-011 in 418 adults having hernia surgery. The goal was to see if it reduces pain and the need for opioid pain pills after the operation. Participants received either HTX-011, a standard painkiller, or a placebo injected int…
Phase: PHASE3 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated May 19, 2026 11:46 UTC
-
New shot eases pain after bunion surgery, study finds
Symptom relief CompletedThis study tested an experimental pain-relief drug called HTX-011 in 430 adults recovering from bunionectomy (foot surgery). The drug was given locally at the surgery site to reduce pain. The main goal was to measure pain intensity over the first 24 hours after surgery. Results s…
Phase: PHASE2 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated May 18, 2026 12:12 UTC
-
New painkillers aim to ease tummy tuck recovery
Symptom relief CompletedThis study tested two experimental drugs, HTX-011 and HTX-002, to see how well they control pain after abdominoplasty (tummy tuck) surgery. About 277 adults participated. The main goal was to measure pain intensity over the first 24 hours after surgery. The study is complete, and…
Phase: PHASE2 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated May 18, 2026 12:04 UTC